Madrigal Pharmaceuticals, Inc. (MDGL)
471.75
-5.16
(-1.08%)
USD |
NASDAQ |
Oct 09, 16:00
471.86
+0.11
(+0.02%)
After-Hours: 20:00
Madrigal Pharmaceuticals Net Income (TTM) : -325.10M for June 30, 2026
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -325.10M |
| March 31, 2026 | -309.44M |
| December 31, 2025 | -288.28M |
| September 30, 2025 | -289.12M |
| June 30, 2025 | -281.90M |
| March 31, 2025 | -391.59M |
| December 31, 2024 | -465.89M |
| September 30, 2024 | -518.67M |
| June 30, 2024 | -510.45M |
| March 31, 2024 | -444.28M |
| December 31, 2023 | -373.63M |
| September 30, 2023 | -347.34M |
| June 30, 2023 | -329.80M |
| March 31, 2023 | -314.73M |
| December 31, 2022 | -295.35M |
| September 30, 2022 | -273.99M |
| June 30, 2022 | -255.90M |
| March 31, 2022 | -246.82M |
| December 31, 2021 | -241.85M |
| September 30, 2021 | -236.42M |
| June 30, 2021 | -231.28M |
| March 31, 2021 | -218.66M |
| December 31, 2020 | -202.24M |
| September 30, 2020 | -170.86M |
| June 30, 2020 | -134.33M |
| Date | Value |
|---|---|
| March 31, 2020 | -105.00M |
| December 31, 2019 | -83.95M |
| September 30, 2019 | -67.68M |
| June 30, 2019 | -54.77M |
| March 31, 2019 | -41.53M |
| December 31, 2018 | -32.81M |
| September 30, 2018 | -29.78M |
| June 30, 2018 | -29.63M |
| March 31, 2018 | -31.52M |
| December 31, 2017 | -31.15M |
| September 30, 2017 | -30.46M |
| June 30, 2017 | -36.14M |
| March 31, 2017 | -30.67M |
| December 31, 2016 | -26.39M |
| September 30, 2016 | -20.52M |
| June 30, 2016 | -8.273M |
| March 31, 2016 | -25.20M |
| December 31, 2015 | -44.19M |
| September 30, 2015 | -62.66M |
| June 30, 2015 | -80.82M |
| March 31, 2015 | -83.31M |
| December 31, 2014 | -86.16M |
| September 30, 2014 | -89.97M |
| June 30, 2014 | -92.52M |
| March 31, 2014 | -93.02M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 807.99M |
| Insmed, Inc. | -875.31M |
| United Therapeutics Corp. | 1.311B |
| Karyopharm Therapeutics, Inc. | -224.74M |
| ACADIA Pharmaceuticals, Inc. | 380.48M |